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Abstract  
Introduction: In March 2020, the World Health Organization introduced the Coronavirus disease 2019 
(COVID-19) pandemic as a global health concern and predicted that without any changes in the transmission 
process, the disease would reach its peak in April. Hence, it was not unreasonable to expect the referral of 
pregnant women in all trimesters. Since respiratory illnesses can increase the risk of infectious diseases and 
maternal mortality, it is justifiable to consider COVID-19-positive cases as high-risk pregnancies.  
Case presentation: The present study introduced six pregnant women with COVID-19 and discussed the 
points to consider in managing these patients. 
Conclusions: Pregnant women are at increased risk in all epidemics of infectious diseases due to their 
physiological and immunological changes. Moreover, the safety of the fetus is another important issue to 
consider. 
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INTRODUCTION
Coronavirus disease 2019 (COVID-19), which 
started in Wuhan, China in late 2019, has rapidly 
spread all around the world, and thousands of 
cases and deaths associated with the virus have 
been reported worldwide (1, 2).  
Pregnancy is a distinctive issue during this 
pandemic, which needs special considerations. 
Since respiratory diseases can increase the chances 
of morbidity and mortality in pregnant women, 
COVID-19-positive cases should be considered 
high-risk pregnancies. During the previous severe 
acute respiratory syndrome (SARS) viral epidemic, 
pregnant women had more serious complications 
than others. Accordingly, the need for mechanical 
ventilation and hospitalization in the intensive care 
unit (ICU) and even death in pregnant women was 
significantly higher than others (3-5). Moreover, 
physiological changes during pregnancy can hide 
many symptoms and delay diagnosis (6, 7). Our 
knowledge about COVID-19 is still limited, and it is 
even more limited regarding its effects on different 
aspects of pregnancy. By reporting the cases, the 
researchers have tried to share their experience in 
this regard. However, in this case series, we also 
aimed to present the clinical findings and 
pregnancy outcomes of some pregnant women 
with COVID-19 and elaborate on the considerable 
points in their management.  
CASE PRESENTATION 
This article presents the clinical findings and 
pregnancy outcomes of six pregnant women with 
COVID-19 who referred to a hospital in Bojnourd, 
Iran, from March 2020 to July 2020. The details of 
each pregnancy are presented in table 1. 
All the pregnant women had respiratory signs and 
symptoms on admission. Three women were also 
febrile, and two had respiratory distress. One of 
them presented with premature rupture of 
membrane, and two had referred due to abnormal 
sonographic findings. It should be mentioned that 
none of the pregnant women had a preexisting 
chronic condition or any underlying disease. 
All the pregnant women were tested for COVID-19, 
using reverse transcription polymerase chain 
reaction (RT-PCR), on the day of admission, the 
results of which were positive in five out of the six 
cases. All six neonates were also tested for COVID-
19 using throat swabs right after birth, and one of 
the test results was positive. Interestingly, the 
positive RT-PCR belonged to the neonate whose 
mother’s RT-PCR was reported negative. 
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Two of the cases had fetal death, probably due to 
prematurity. Their gestational ages were 14 and 31 
weeks. The result of RT-PCR for COVID-19 was 
reported positive in one of the two fetal deaths. 
Their mothers did not mention any problem or risk 
factors before or during pregnancy; however, the 
pregnancy in both cases had to be terminated due 
to fetal death. One of them was referred due to 
abnormal sonography findings (gestational sac 
without fetal pole) and the other one visited due to 
reduced fetal movements. 
The fourth case’s neonate developed respiratory 
distress and decreased arterial blood oxygen 
saturation right after delivery. He recovered after 
nasal oxygen therapy for 2 hours without further 
interventions.  
The mothers underwent high-resolution lung 
computed tomography (CT) scan after delivery and 
pulmonary involvement was obvious in all of them. 
Although clinical manifestation and lung CT scan 
were suggestive of COVID-19 in all cases, the RT-
PCR test result of one of the mothers was negative 
for SARS-CoV-2. This was the case whose neonate 
was stillborn, and of course the neonate’s PCR test 
was positive, unlike the mother. 
None of our patients received antiviral therapies, 
but all of them became symptom-free soon after the 
birth and were followed up only for complications. 
It is noteworthy that none of the survived neonates 
required mechanical ventilation. Cases number 
three and four were discharged after 3 and 7 days, 
respectively; the longer hospital stay was due to 
poor feeding. The first two neonates and their 
mothers were discharged the day after the birth. All 
Table 1: Characteristics of Six Pregnant Women with COVID-19 and their neonates 
Case 6 Case 5 Case 4 Case 3 Case 2 Case 1 Variable 
33 27 22 25 38 15 
Maternal age  
(yrs.) 
G3 G5 G2 G4 G4 G1 Gravity 




21 19 16 19 25 23 
Respiratory rate 
(/min) 
94 96 96 96 92 94 
O2 saturation  
on admission 
(%) 






































- - Fetal distress PROM Comorbidity  




NVD NVD NVD NVD CS NVD Delivery type 
1090 300 3170 2730 3210 2140 Birth weight (g) 
Death Death 8 9 6 7 
Apgar scores at 
1 min 
Death Death 10 10 10 9 
Apgar scores at 
5 min 




- - Uterine Atony - Uterine Atony - 
Delivery related 
complications  
PCR: polymerase chain reaction, SARS: severe acute respiratory syndrome, COV: Coronavirus, HRCT: high-resolution computed 
tomography, PROM: premature rupture of membrane, NVD: normal vaginal delivery, CS: cesarean section 
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mothers and survived neonates received 
supportive care and were discharged from the 
hospital without any important complications. 
In the four surviving cases discussed in this article, 
the newborns were healthy and breastfeeding was 
not associated with an increased risk for the 
infants. Neonates were followed up for 28 days 
after the birth and none of them developed COVID-
19-related signs and symptoms. 
DISCUSSION 
With its rapid outbreak, COVID-19 has significantly 
affected public health and medical infrastructure. 
In this regard, the transmission of the disease and 
its diagnosis in pregnant women and their fetuses 
as well as their safety are matters of concern. 
Recent studies have shown that mortality in 
pregnant patients with COVID-19 is less than 1%, 
which is much lower than that of SARS and Middle 
East respiratory syndrome (MERS); but it is still 
considerable in comparison with non-pregnant 
women in the same age (8). Based on the World 
Health Organization (WHO) reports, there is an 
increased risk of developing severe COVID-19 in 
older or overweight pregnant women (3). 
Moreover, it is estimated that pregnant women 
with severe COVID-19 more frequently need ICU 
admission in comparison with non-pregnant ones 
(3). Among the normal components of pregnancy, 
there are physiological and immunological changes 
which can raise the risk of complication due to 
infection. Changes in lung capacity, oxygen 
consumption, and stroke volume as well as 
immunologic adaptations during pregnancy allow 
the mother to tolerate a fetus with distinct 
antigenic components (4-6). 
In a recently published review on COVID-19 during 
pregnancy, it was suggested that the majority of the 
cases experienced mild to moderate symptoms, 
fatigue and fever were the most common 
complaints (2). It should be mentioned that three 
of our patients had a fever at the time of admission 
and the others had experienced it in the previous 
week. All of them complained of shortness of 
breath, which can also be explained by the 
pregnancy.  
There is evidence of renin-angiotensin-aldosterone 
system and coagulation abnormalities, endothelial 
malfunctions, and complement activation in 
COVID-19 patients, which is a mimic of 
preeclamptic pregnancies (2). Furthermore, 
cytokine storm caused by tissue injury in COVID-19 
might be significantly modified in pregnancy due to 
changes in immune responses, which may affect 
laboratory and clinical characteristics of the 
disease during pregnancy (2, 3). 
The current diagnostic standard test for COVID-19 
is quantitative RT-PCR (9). Interestingly, in one of 
our cases, RT-PCR of the mother for COVID-19 was 
negative, while her fetus tested positive. We 
considered two hypotheses to explain it. First, the 
mother’s test was a false negative one and the virus 
was transmitted from the mother to the fetus 
during pregnancy. Possibility of vertical 
transmission of the virus from mother to infant has 
also been suggested in the literature, although the 
risk is very low due to the absence of the virus in 
amniotic fluid, umbilical cord, breast milk, and 
neonatal swabs (10, 11). Second, it may be 
transmitted via vaginal contact with father’s semen 
during intercourse. The published data about 
sexual transmission of SARS-CoV-2 indicates the 
unlikely that its transmission through semen is 
unlikely (12). We could not have access to the 
screening test of her husband; therefore, we cannot 
confidently suggest if the test of the mother was 
false negative or it was sexually transmitted. 
Moreover, it is not fully determined whether the 
virus can be transmitted to the fetus during 
pregnancy or delivery (2). 
In the cases reported in this paper, lung High-
resolution computed tomography (HRCT) was 
performed after delivery and all six cases had some 
degree of pulmonary involvement. We preferred to 
postpone performing CT scan to after delivery 
since all cases were at the delivery phase and there 
was no emergent need for the diagnosis of 
pulmonary involvement. There is always the 
possibility of teratogenicity of radiation during 
pregnancy, although it is very low. According to the 
available statistics, performing a lung CT scan at 
0.03 mGy is not associated with an increased risk of 
fetal anomalies and pregnancy complications (13, 
14). 
It should be noted that there is a risk of developing 
postpartum respiratory symptoms in mothers. In 
one of our cases, respiratory symptoms appeared 
after delivery, which could be suggestive of other 
differential diagnoses, such as amniotic fluid 
embolism, in addition to COVID-19. As in any other 
case, viral pulmonary involvement is associated 
with an increased risk of bacterial infections; 
hence, progressive manifestation is justifiable. 
Therefore, careful examination of suspected 
patients is necessary to reduce diagnostic and 
therapeutic errors. Respiratory monitoring and 
follow-up are also recommended for a period after 
delivery in pregnant women with COVID-19 (8). 
There is no complete consensus on the treatment 
of pregnant women with COVID-19. However, 
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WHO emphasizes the uselessness of systemic 
corticosteroids in these patients and does not 
recommend them except in cases of medical 
indication (3). Besides, corticosteroids can 
suppress the production of antibodies in the 
mother and increase the chances of infecting the 
fetus or infant (2, 15). Another medication that was 
previously administered to treat these cases was 
chloroquine phosphate. Although the medication 
and its metabolites pass through the placenta, no 
dangerous neonatal complication has been 
reported so far (16). Volume of distribution for 
chloroquine increases during pregnancy and its 
serum level decreases; hence, if administered, 
higher doses may be needed during this time (15). 
Quinolones are not presently recommended for 
treatment of COVID-19. 
Prolonged maternal hypoxia can be associated with 
placental hypo-perfusion and fetal growth 
retardation. In the cases reported in this paper, the 
infants did not have developmental disorders, 
which can be explained by the infection of the 
mother in the late stages of pregnancy and the 
shorter period of the disease. It is generally 
recommended that pregnant women undergo at 
least one ultrasound to check for intrauterine 
growth disorder after recovery from COVID-19 (8).  
In our cases, two mothers experienced atony and 
post-partum hemorrhage, which were controlled 
via conservative treatments. It should be noted that 
maternal hypoxia might be associated with uterine 
atony. Preventive use of long-acting uterotonic 
agents is recommended to reduce the incidence of 
postpartum hemorrhage in COVID-19 cases (17).   
The preferred method of delivery in critically ill 
patients is cesarean section. Common analgesia can 
be used in patients with a good general condition 
and stable symptoms. However, the use of nitrogen 
inhalation is not recommended due to the 
increased risk of infection (8, 17). Pregnant women 
who have tested positive for COVID-19 can try 
vaginal delivery without exacerbation of their 
disease or an increased risk for SARS-CoV-2 
infection in their neonates (17). 
In pregnant mothers with suspected COVID-19 
who need adjuvant oxygen therapy with a nasal 
cannula, it is recommended that a surgical mask be 
placed on the cannula to reduce the risk of 
transmission (8). In the guideline regarding SARS, 
the Canadian Women's Foundation suggests that 
umbilical cord clamping should not be delayed and 
there should not be skin contact immediately after 
delivery (4). Nevertheless, the necessity of these 
measures has not been proven for COVID-19.  
Breastfeeding is also ambiguous in cases of COVID-
19 and is not recommended, and if the patient 
insists, the mother must have a mask. However, the 
milk of women with SARS has not been proven to 
have a significant viral load (8). Regarding the 
cases reported in this study, it was decided to allow 
the breastfeeding of neonates since the risk of 
death due to malnutrition was much higher than 
coronavirus-related death. 
CONCLUSIONS 
Pregnant women are at increased risk in all 
epidemics of infectious diseases due to their 
physiological and immunological changes. 
Moreover, the safety of the fetus is another 
important issue to be considered. 
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